Mithu Maheswaranathan, MD
@mithurheum.bsky.social
🩺 Rheumatologist at Duke School of Medicine
🎨 Creator of Rheum OnePagers
🧑🏽💻 Infographics • MedEd • Lupus • Health Literacy
🎨 Creator of Rheum OnePagers
🧑🏽💻 Infographics • MedEd • Lupus • Health Literacy
🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋
Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities
➠ Read the Full Guideline here: acr.tw/47mkegj
#RheumSky #SLE #Rheumatology
Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities
➠ Read the Full Guideline here: acr.tw/47mkegj
#RheumSky #SLE #Rheumatology
November 5, 2025 at 6:28 PM
🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋
Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities
➠ Read the Full Guideline here: acr.tw/47mkegj
#RheumSky #SLE #Rheumatology
Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities
➠ Read the Full Guideline here: acr.tw/47mkegj
#RheumSky #SLE #Rheumatology
Reposted by Mithu Maheswaranathan, MD
That’s a wrap on #ACR25. Great to connect with the #rheumsky #meded community IRL! @davidleverenz.bsky.social @mithurheum.bsky.social @pedsrheum2connect.bsky.social @washumedrheum.bsky.social
October 30, 2025 at 1:11 PM
That’s a wrap on #ACR25. Great to connect with the #rheumsky #meded community IRL! @davidleverenz.bsky.social @mithurheum.bsky.social @pedsrheum2connect.bsky.social @washumedrheum.bsky.social
🆕 Clinical Year in Review at #ACR25
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
October 29, 2025 at 6:00 PM
🆕 Clinical Year in Review at #ACR25
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
🆕 Secrets & Pearls of #Rheumatology at #ACR25 | Part 1 by Dr. Janet Pope
🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
October 28, 2025 at 11:02 PM
🆕 Secrets & Pearls of #Rheumatology at #ACR25 | Part 1 by Dr. Janet Pope
🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
October 26, 2025 at 2:56 PM
🆕 Collaboration with RheumNow 🔵
3-Part Series on Interstitial Lung Disease
Part 2: Diagnosis & Subtypes of #ILD
👩🏻⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging
#RheumSky #PulmSky #MedSky #InterstitialLungDisease
3-Part Series on Interstitial Lung Disease
Part 2: Diagnosis & Subtypes of #ILD
👩🏻⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging
#RheumSky #PulmSky #MedSky #InterstitialLungDisease
September 17, 2025 at 5:40 PM
🆕 Collaboration with RheumNow 🔵
3-Part Series on Interstitial Lung Disease
Part 2: Diagnosis & Subtypes of #ILD
👩🏻⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging
#RheumSky #PulmSky #MedSky #InterstitialLungDisease
3-Part Series on Interstitial Lung Disease
Part 2: Diagnosis & Subtypes of #ILD
👩🏻⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging
#RheumSky #PulmSky #MedSky #InterstitialLungDisease
🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫
👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy
#RheumSky #Behcets #Rheumatology
👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy
#RheumSky #Behcets #Rheumatology
August 6, 2025 at 5:25 PM
🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫
👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy
#RheumSky #Behcets #Rheumatology
👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy
#RheumSky #Behcets #Rheumatology
🆕 2024 ACR Guidelines for Screening, Treatment and Management of Lupus Nephritis 🫘
• Just Released: May 7, 2025 🔥
🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊
#LupusNephritis #RheumSky #NephSky #Lupus
• Just Released: May 7, 2025 🔥
🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊
#LupusNephritis #RheumSky #NephSky #Lupus
May 8, 2025 at 9:18 PM
🆕 2024 ACR Guidelines for Screening, Treatment and Management of Lupus Nephritis 🫘
• Just Released: May 7, 2025 🔥
🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊
#LupusNephritis #RheumSky #NephSky #Lupus
• Just Released: May 7, 2025 🔥
🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊
#LupusNephritis #RheumSky #NephSky #Lupus
🆕 PJP Prophylaxis in #Rheumatology 🫁
🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?
#MedSky #RheumSky #PulmSky #PJP
🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?
#MedSky #RheumSky #PulmSky #PJP
March 27, 2025 at 6:14 PM
🆕 PJP Prophylaxis in #Rheumatology 🫁
🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?
#MedSky #RheumSky #PulmSky #PJP
🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?
#MedSky #RheumSky #PulmSky #PJP
💫 Check out the new Rheum Madness x Rheum One Pagers bracket infographic! 🎉🏀📟
📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1
@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social
📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1
@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social
March 19, 2025 at 5:02 PM
💫 Check out the new Rheum Madness x Rheum One Pagers bracket infographic! 🎉🏀📟
📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1
@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social
📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1
@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social
🆕 #Obinutuzumab (Obi) in Lupus Nephritis: the REGENCY Trial
Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes
#LupusNephritis #RheumSky #NephSky #MedSky #Lupus
Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes
#LupusNephritis #RheumSky #NephSky #MedSky #Lupus
February 12, 2025 at 10:16 PM
🆕 #Obinutuzumab (Obi) in Lupus Nephritis: the REGENCY Trial
Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes
#LupusNephritis #RheumSky #NephSky #MedSky #Lupus
Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes
#LupusNephritis #RheumSky #NephSky #MedSky #Lupus
🆕 Visual Abstract with Healio Rheumatology 🟢
🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB
💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission
#IgG4RD #RareDiseases #Rheumatology #Inebilizumab
🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB
💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission
#IgG4RD #RareDiseases #Rheumatology #Inebilizumab
December 16, 2024 at 6:52 PM
🆕 Visual Abstract with Healio Rheumatology 🟢
🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB
💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission
#IgG4RD #RareDiseases #Rheumatology #Inebilizumab
🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB
💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission
#IgG4RD #RareDiseases #Rheumatology #Inebilizumab
Reposted by Mithu Maheswaranathan, MD
Happy holidays from the Duke Rheum crew ❄️ ⛄️ 🎄 @mithurheum.bsky.social
December 8, 2024 at 3:16 PM
Happy holidays from the Duke Rheum crew ❄️ ⛄️ 🎄 @mithurheum.bsky.social
Excited to have the opportunity to present on Physician #Burnout in Rheumatology at our division Grand Rounds today.
Thankful many advocates have been voices on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!
Thankful many advocates have been voices on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!
December 4, 2024 at 12:51 AM
Excited to have the opportunity to present on Physician #Burnout in Rheumatology at our division Grand Rounds today.
Thankful many advocates have been voices on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!
Thankful many advocates have been voices on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!
🆕 #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management 🫘
Highlights 🔶
• Critical role of renal biopsy
• Differences for treatment by LN Class
• Adjunctive Rx w/ HCQ & RAASi
• GC pulse ⇢ *moderate/low* dose PDN
#Lupus #NephSky #RheumSky #Rheumatology #MedSky
Highlights 🔶
• Critical role of renal biopsy
• Differences for treatment by LN Class
• Adjunctive Rx w/ HCQ & RAASi
• GC pulse ⇢ *moderate/low* dose PDN
#Lupus #NephSky #RheumSky #Rheumatology #MedSky
November 18, 2024 at 11:37 PM
#ACR24 Lupus Nephritis CARE
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
November 18, 2024 at 1:27 PM
#ACR24 Lupus Nephritis CARE
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
🆕 The Great Debate at #ACR24: Is Mixed Connective Tissue Disease (MCTD) a distinct disease entity?
🗳️ Final Vote (n=430 votes)
• 51% = MCTD *is* a unique disease
• 49% = MCTD is not a unique disease
#MixedConnectiveTissueDisease #Rheumatology #RheumSky #MCTD
🗳️ Final Vote (n=430 votes)
• 51% = MCTD *is* a unique disease
• 49% = MCTD is not a unique disease
#MixedConnectiveTissueDisease #Rheumatology #RheumSky #MCTD
November 17, 2024 at 10:14 PM
🆕 The Great Debate at #ACR24: Is Mixed Connective Tissue Disease (MCTD) a distinct disease entity?
🗳️ Final Vote (n=430 votes)
• 51% = MCTD *is* a unique disease
• 49% = MCTD is not a unique disease
#MixedConnectiveTissueDisease #Rheumatology #RheumSky #MCTD
🗳️ Final Vote (n=430 votes)
• 51% = MCTD *is* a unique disease
• 49% = MCTD is not a unique disease
#MixedConnectiveTissueDisease #Rheumatology #RheumSky #MCTD
Clinical Year in Review at #ACR24
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
November 17, 2024 at 2:40 PM
Clinical Year in Review at #ACR24
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Congratulations to @sjbracken.bsky.social & all the ACR Distinguished Fellow award recipients at #ACR24 🥇
Anyone who knows Sonali knows how dedicated and hardworking she is — from her research to patient care — working to improve the lives of patients with #scleroderma! #DukeRheum
Anyone who knows Sonali knows how dedicated and hardworking she is — from her research to patient care — working to improve the lives of patients with #scleroderma! #DukeRheum
November 16, 2024 at 12:09 AM
Congratulations to @sjbracken.bsky.social & all the ACR Distinguished Fellow award recipients at #ACR24 🥇
Anyone who knows Sonali knows how dedicated and hardworking she is — from her research to patient care — working to improve the lives of patients with #scleroderma! #DukeRheum
Anyone who knows Sonali knows how dedicated and hardworking she is — from her research to patient care — working to improve the lives of patients with #scleroderma! #DukeRheum
Hi #MedSky 👋🏽 #FirstPost
I’m Mithu, a rheumatologist who loves all things rheum & creating infographics to explain complex rheum topics!
Hope to share more on systemic autoimmune diseases here! Excited to see this new community grow & for #ACR24 this week 🥳
#RheumSky #Rheumatology #MedEd
I’m Mithu, a rheumatologist who loves all things rheum & creating infographics to explain complex rheum topics!
Hope to share more on systemic autoimmune diseases here! Excited to see this new community grow & for #ACR24 this week 🥳
#RheumSky #Rheumatology #MedEd
November 13, 2024 at 8:18 PM
Hi #MedSky 👋🏽 #FirstPost
I’m Mithu, a rheumatologist who loves all things rheum & creating infographics to explain complex rheum topics!
Hope to share more on systemic autoimmune diseases here! Excited to see this new community grow & for #ACR24 this week 🥳
#RheumSky #Rheumatology #MedEd
I’m Mithu, a rheumatologist who loves all things rheum & creating infographics to explain complex rheum topics!
Hope to share more on systemic autoimmune diseases here! Excited to see this new community grow & for #ACR24 this week 🥳
#RheumSky #Rheumatology #MedEd